Exhibit 10.1






Exhibit 10.1




EMPLOYMENT AGREEMENT




     THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of June 23, 2008, by and
between MEDCATH CORPORATION, a Delaware corporation (the “Company”), and JEFFREY HINTON
(“Executive”).



RECITALS




     The Company desires to employ Executive to serve as an Executive Vice President and as its
Chief Financial Officer, and Executive is willing to accept such employment and perform services
for the Company, all on the terms and conditions hereinafter set forth.



     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties hereto agree as follows:



     1. Employment.



          1.1 Position. Subject to the terms and conditions of this Agreement, the Company
agrees to employ Executive during the term hereof as an Executive Vice President and as its Chief
Financial Officer. In such capacity, Executive shall report to the Chief Executive Officer of the
Company (the “CEO”) and shall have the customary powers, responsibilities and authorities
of such position and office for corporations of the size and character of the Company, as it exists
from time to time and as are assigned by the CEO.




          1.2 Duties. Subject to the terms and conditions of this Agreement, Executive hereby
accepts employment with the Company commencing on June 23, 2008 and agrees to devote his full
working time and efforts, to the best of his ability, experience and talent, to the performance of
services, duties and responsibilities in connection therewith. Executive shall perform such duties
and exercise such powers, commensurate with his position, as the CEO shall from time to time
delegate to him on such terms and conditions and subject to such restrictions as the board of
directors of the Company (the “Board”) may reasonably from time to time impose.




          1.3 Outside Activities. Nothing in this Agreement shall preclude Executive (i) from
engaging in charitable and community affairs, from managing any passive investment made by him in
publicly traded equity securities or other property (provided that no such investment may exceed 5%
of the equity of any entity) or (ii) subject to Section 13(b) hereof, from serving as a member of
boards of directors or as a trustee of any other corporation, association or entity,




 









 




so long as in the reasonable determination of the CEO and none of the activities described in
clauses (i) or (ii) interferes with his duties and responsibilities hereunder.




     2. Term of Employment. Executive’s term of employment under this Agreement shall
commence on the Commencement Date and, subject to the terms hereof, shall terminate on the third
anniversary of the Commencement Date; provided, however, that the term of this
Agreement and Executive’s employment hereunder shall be automatically renewed and extended for
additional one-year periods commencing on the third anniversary of the Commencement Date and on
each anniversary date thereafter, unless the Company or Executive provides written notice to the
other party, at least 90 days prior to the expiration of the initial term or any renewal term, of
the non-renewal of this Agreement.



     3. Compensation.



          3.1 Salary. The Company shall pay Executive a base salary (“Base Salary”) at
the rate of $350,000 per annum commencing as of the Commencement Date. Base Salary shall be
adjusted annually at the discretion of the Board but in no event shall Base Salary be reduced nor
be less than the median base salary for a comparable position at corporations of similar size and
character as the Company, as it exists from time to time, and, as increased, shall constitute “Base
Salary” hereunder. Base Salary shall be payable in accordance with the normal payroll practices of
the Company but no less frequently than monthly.




          3.2 Bonus. For each fiscal year of Executive’s employment hereunder, Executive shall
participate in the bonus plan established for the Company’s senior executives. Executive’s target
bonus with respect to each such fiscal year shall be equal to 50% of Executive’s Base Salary for
such fiscal year (the “Target Bonus”). The Board (or a committee thereof) shall have
complete authority to establish all other terms and provisions of the bonus plan, including the
performance goals for the bonus plan, the threshold performance required for the payment of any
bonus under the plan, the maximum bonus opportunity for Executive under the plan, and the total
cash compensation consistent with its exercise of discretion.. Bonuses shall be paid within 2-1/2
months following the fiscal year to which they relate, and Executive must be employed by the
Company on the day the bonus is payable to be eligible to receive the bonus.




          3.3 Compensation Plans and Programs. Executive shall be eligible to participate in
any other compensation plan or program maintained by the Company from time for




2









 




senior executives of the Company on terms and conditions that are comparable to those applicable to
such other senior executives.




     4. Employee Benefits.



          4.1 Employee Benefit Programs, Plans and Practices. The Company shall provide
Executive during the term of his employment hereunder with participation in or coverage under all
employee pension and welfare benefit programs, plans and practices (commensurate with his position
in the Company from time to time and to the extent permitted under any employee benefit plan) which
the Company makes available to its senior executives. Executive agrees to waive his right to
participate in the Employee Health Insurance Plan for a period that includes his participation in
the health plan provided by his immediately former employer, such participation expecting to last
until approximately mid-2010.




          4.2 Vacation and Fringe Benefits. Executive shall be entitled to no less than the
number of business days paid vacation in each calendar year which have historically been provided
to similarly situated executives, which shall be taken at such times as are consistent with
Executive’s responsibilities hereunder but which shall not have any year-to-year carryover. In
addition, Executive shall be entitled to the perquisites and other fringe benefits currently made
available to senior executives of the Company, commensurate with his position with the Company.




          4.3 Relocation Expenses. Executive shall become a full-time resident of the
Charlotte, North Carolina area no later than the Commencement Date and shall relocate his family to
the Charlotte, North Carolina area as soon as practicable thereafter. Executive shall utilize the
Company’s retained relocation firm (Xonex) for all relocation efforts. Company shall be
responsible for reimbursement of the real estate brokerage commission on the sale of Executive’s
current principal residence in Georgia provided that Executive utilizes the services of Xonex in
listing and selling Executive’s home, and ensures that the maximum economic benefit of Xonex is
realized in the transaction. Any expenses incurred by Executive in the relocation process which are
not covered by the Company’s agreement with Xonex are the sole responsibility of Executive, absent
prior approval from the Company. Any reasonable and customary expenses incurred by Executive and
reimbursed by Company shall be treated as after tax income.




3









 





     5. Expenses. Executive is authorized to incur reasonable expenses in carrying out his
duties and responsibilities under this Agreement, including, without limitation, expenses for
travel and similar items related to such duties and responsibilities. The Company will reimburse
Executive for all such expenses upon presentation by Executive from time to time of appropriately
itemized and approved (consistent with the Company’s policy) accounts of such expenditures.



     6. Termination of Employment.



          6.1 Termination By the Company Without Cause or By Executive for Good Reason. (a) The
Company may terminate Executive’s employment under this Agreement at any time for any reason,
provided that any such termination other than for Cause (as defined in Section 6.4 hereof)
may only be made upon 30 days prior written notice to Executive. If Executive’s employment under
this Agreement is terminated by the Company without Cause (other than as a result of Executive’s
death or Permanent Disability (as defined in Section 6.2 hereof) or if Executive terminates his
employment for Good Reason (as defined in Section 6.1(c) hereof), Executive shall receive any
payments to which he is entitled under any applicable compensation or employee benefit plan or
program in which he participates, including but not limited to those referred to in Section 3.3
hereof. In addition, in the event of any such termination described in the immediately preceding
sentence, Executive shall be entitled to receive the following:





     (i) an amount equal to the sum of (A) one times Executive’s Base Salary if
such termination occurs prior to a Change in Control ( as defined in 6.1(c) hereof)
or more than 12 months after a Change in Control or (B) if such termination occurs
upon a Change in Control or at any time within 12 months after a Change in Control,
the sum of two times Executive’s Base Salary and one times Executive’s Target Bonus
(such amount, the “Severance Payment”);




     (ii) a cash lump sum payment in respect of (x) compensation earned but not
yet paid (including any awarded but deferred Bonus payments) (the “Compensation
Payment”), and (y) reasonable expenses incurred under Section 5 but not yet
reimbursed (the “Expense Payment”); and




     (iii) after waiver period for health coverage in 4.1, continued coverage under
the Company’s group medical plan in accordance with the terms thereof for a period
ending on the earlier of (A) the second anniversary of the date of termination
under this Section 6.1(a) or (B) the date on which Executive becomes eligible to be
covered under comparable benefit plans of a new employer (the “Coverage
Period”), provided that Executive shall be required to contribute an
amount toward the cost for such coverage during the Coverage



4









 







Period that is equal to the cost paid by active employees of the Company for
coverage under the Company’s group medical plan during the Coverage Period, and for
purposes of applying the group health plan coverage continuation requirements of
Section 4980B of the Internal Revenue Code of 1986 and Section 601 et
seq. of the Employee Retirement Income Security Act of 1974, as amended,
the “qualifying event” shall be the termination of the Executive’s employment with
the Company.



          (b) The Severance Payment shall be paid by the Company to Executive over the 12 month period
following the date of termination in substantially equal installment payments and in accordance
with the normal payroll practices of the Company but no less frequently than monthly. The
Compensation Payment and the Expense Payment shall be paid by the Company to Executive in a cash
lump sum payment within 30 days after the date of termination.




          (c) For purposes of this Agreement, “Good Reason” shall mean any of the following
(without Executive’s express prior written consent):





     (i) A substantial reduction or elimination of Executive’s management
responsibility for the financial operations of the Company, other than in connection
with the termination of Executive’s employment by the Company for Cause, by
Executive without Good Reason or as a result of Executive’s Permanent Disability or
death;




     (ii) A reduction by the Company in Executive’s Base Salary or Target Bonus; or




     (iii) A reduction or elimination of Executive’s eligibility to participate in
any of the Company’s employee benefit plans that is inconsistent with the
eligibility of similarly situated executives of the Company to participate therein;



     (iv)
A required relocation of Executive’s principal place of
employment that is more than 25 miles from his initial place of
employment.



     (v)
The Company provides Executive written notice of the
non-renewal of this agreement pursuant to Section 2



For purposes of this Agreement, “Change in Control” shall mean:





     (i) Sales of all or substantially all of the assets of the Company, MedCath
Holdings Corp. or MedCath Incorporated to an individual, partnership, corporation,
business trust, joint stock company, trust, unincorporated association, joint
venture, governmental authority or other entity (a “Person”) who is not an
affiliate of Welsh, Cason, Anderson & Stowe, VII, L.P. (“WCAS”);




     (ii) A sale by WCAS or any of its respective affiliates resulting in



5









 







more than 50% of the voting stock of the Company, MedCath Holdings Corp. or
MedCath Incorporated being held by a person or group that does not include or WCAS
or any of their respective affiliates; or




     (iii) A merger or consolidation of the Company, MedCath Holdings
Corp. or MedCath Incorporated into another Person which is not an affiliate of or
WCAS;


if and only if any such event results in the inability of WCAS, or any of their respective
affiliates (collectively, the "Partnerships”) to elect a majority of the Board of
Directors of the Company (or the resulting entity);




          6.2 Permanent Disability. If Executive becomes totally and permanently disabled (as
defined in the Company’s Long-Term Disability Benefit Plan applicable to senior executive officers
as in effect on the date hereof) (“Permanent Disability”), the Company or Executive may
terminate Executive’s employment under this Agreement upon 30 days prior written notice thereof,
and Executive shall receive or commence receiving, as soon as practicable:





     (i) amounts payable pursuant to the terms of a disability insurance policy or
similar arrangement which the Company maintains during the term hereof;




     (ii) Executive’s Target Bonus in respect of the fiscal year in which his
termination occurs, prorated by a fraction, the numerator of which is the number of
days of the fiscal year until termination and the denominator of which is 365;




     (iii) the Compensation Payment, and the Expense Payment; and




     (iv) any payments to which he is entitled under any applicable compensation or
employee benefit plan or program in which he participates, including but not limited
to those referred to in Section 3.3 hereof.



          6.3 Death. In the event of Executive’s death during the term of his employment
hereunder, Executive’s estate or designated beneficiaries shall receive or commence receiving, as
soon as practicable:





     (i) Executive’s Target Bonus in respect of the fiscal year in which his death
occurs, prorated by a fraction, the numerator of which is the number of days of the
fiscal year until his death and the denominator of which is 365;




     (ii) any death benefits provided under the employee benefit programs, plans and
practices referred to in Section 4.1 hereof, in accordance with their terms;




     (iii) the Vacation Payment, the Compensation Payment, and the Expense Payment;
and




6












 






     (iv) any payments to which he is entitled under any applicable compensation or
employee benefit plan or program in which he participates, including but not limited
to those referred to in Section 3.3 hereof.



          6.4 Termination By the Company for Cause or By Executive without Good Reason. (a) The
Company shall have the right to immediately terminate the employment of Executive under this
Agreement for Cause, and Executive shall have the right to terminate his employment under this
Agreement without Good Reason upon 90 days prior written notice to the Company. In the event that
Executive’s employment is terminated by the Company for Cause or by Executive without Good Reason,
notwithstanding any other provision in this Agreement, Executive shall be entitled only to the
Compensation Payment, and the Expense Payment, and shall not be entitled to any further
compensation or benefits hereunder including, without limitation, the payment of any bonus in
respect of all or any portion of the fiscal year in which such termination occurs. Nothing herein
shall be construed to limit, abolish, or otherwise interfere with benefits accrued by Executive at
time of termination, including but not limited to accrued vacation, 401(k) benefits, etc.




          (b) As used herein, the term “Cause” shall mean and be limited to (i) willful
misconduct by Executive which results in a demonstrable injury (which is other than de minimis or
insignificant) to the Company, (ii) willful and continued failure by Executive to perform his
material duties with respect to the Company or its subsidiaries, which failure continues beyond 10
days after a written demand for substantial performance of such duties was given to Executive by
the Company, or (iii) Executive’s conviction of, or plea of nolo contendere to, a
felony or to a misdemeanor involving moral turpitude. Termination of Executive for Cause pursuant
to Section 6.4(a) shall be made by delivery to Executive of written notice that, in the reasonable
judgment of the Board, Executive was guilty of conduct set forth in any of clauses (i) through
(iii) above and specifying the particulars thereof.




     7. Release. Notwithstanding anything to the contrary contained herein, the Company
shall not be obligated to pay Executive the Severance Payment pursuant to Section 6.1 in the event
Executive’s employment is terminated by the Company without Cause (other than as a result of
Executive’s death or Permanent Disability) or by Executive for Good Reason and any options held by
Executive to purchase the Company’s common stock shall not be exercisable after the termination of
the Executive’s employment hereunder unless the Executive executes and delivers to the Company a
release, dated the date of his termination of employment, to the



7









 







effect that: for good and valuable
consideration, the Executive unconditionally releases and covenants not to sue the Company and its
subsidiaries and affiliates and directors, officers, employees and stockholders thereof, from any
and all claims, liabilities and obligation of any nature pertaining to termination of employment other than those
explicitly provided for by this Agreement including, without limitation, any claims arising out of
alleged legal restrictions on the Company’s right to terminate its employees, such as any implied
contract of employment or termination contrary to public policy or to laws prohibiting
discrimination (including, without limitation, the Age Discrimination in Employment Act); and
containing such other provisions as the Company may request to effect the purposes of the foregoing
release. Said release shall not affect or abrogate the Company’s obligations under the herein
agreement, any vested benefit, or any rights granted to the Executive under the Company’s by-laws,
charter, or applicable law.



     8. Mitigation of Damages. Executive shall not be required to mitigate damages or the
amount of any payment provided for under this Agreement by seeking other employment or otherwise
after the termination of his employment hereunder.



     9. Notices. All notices or communications hereunder shall be in writing, addressed as follows:


To the Company:



MedCath Corporation

10720 Sikes Place, Suite 300

Charlotte, North Carolina 28277

Attn: Chief Executive Officer


with a copy to:



Hal A. Levinson, Esq.

Moore & Van Allen, PLLC

100 N. Tryon Street, Floor 47

Charlotte, North Carolina 28202-4003



To Executive:



Jeffrey Hinton

[the most recent address

on the Company’s employment

records for Executive]



Any such notice or communication shall be delivered by hand, by telecopy (with machine
confirmation) or by courier or sent certified or registered mail, return receipt requested, postage
prepaid, addressed as above (or to such other address as such party may designate in a notice




8









 





duly
delivered as described above), and the third business day after the actual date of mailing shall
constitute the time at which notice was given.




     10. Separability; Legal Fees. If any provision of this Agreement shall be declared to
be invalid or unenforceable, in whole or in part, such invalidity or unenforceability shall not
affect the remaining provisions hereof which shall remain in full force and effect. Each party
shall bear the costs of any legal fees and other fees and expenses which may be incurred in respect
of enforcing its respective rights under this Agreement.



     11. Assignment. This Agreement shall be binding upon and inure to the benefit of the
heirs and representatives of Executive and the assigns and successors of the Company, but neither
this Agreement nor any rights or obligations hereunder shall be assignable or otherwise subject to
hypothecation by Executive (except by will or by operation of the laws of intestate succession) or
by the Company, except that the Company may assign this Agreement to any successor (whether by
merger, purchase or otherwise) to all or substantially all of the stock,
assets or businesses of the Company, if such successor expressly agrees to assume the obligations
of the Company hereunder.



     12. Amendment. This Agreement may only be amended by written agreement of the parties
hereto.



     13. Nondisclosure of Confidential Information; Non-Competition; Non-Disparagement.
(a) At any time during or after Executive’s employment with the Company, Executive shall not,
without the prior written consent of the Company, use, divulge, disclose or make accessible to any
other person, firm, partnership, corporation or other entity any Confidential Information (as
hereinafter defined) pertaining to the business of the Company or any of its subsidiaries, except
(i) while employed by the Company, in the business of and for the benefit of the Company, or (ii)
when required to do so by a court of competent jurisdiction, by any governmental agency having
supervisory authority over the business of the Company, or by any administrative body or
legislative body (including a committee thereof) with jurisdiction to order Executive to divulge,
disclose or make accessible such information. For purposes of this Section 13(a),
“Confidential Information” shall mean non-public information concerning the financial data,
strategic business plans, and other non-public, proprietary and confidential information of the
Company, its subsidiaries, Welsh, Carson, Anderson & Stowe VII, L.P., or their respective
affiliates as in existence as of the date of Executive’s termination of employment



9









 







that, in any
case, is not otherwise available to the public (other than by Executive’s breach of the terms
hereof). Confidential Information further includes without limitation customer information,
vendors, operations and operating procedures, pricing, financial information, technology, marketing
strategies, design of facilities, employment practices, contractual agreements, and trade secrets.



          Executive agrees that both while employed by the Company and following termination of
Executive’s employment with the Company at any time in the future:





     (i) Executive will take all reasonable precautions to safeguard all
Confidential Information at all times so that it is not communicated to, exposed to,
available to, or taken by any unauthorized person and will personally use or
disclose such information; and




     (ii) Executive will exercise Executive’s reasonable best efforts to assure the
safekeeping of the Company’s Confidential Information.



          Upon termination of Executive’s employment with the Company, Executive agrees to immediately
return to the Company all Confidential Information and other Company property, including without
limitation all originals, copies, computer data, or other records or information. It is understood
and agreed that Confidential Information and other property of the Company shall remain at all
times the property of the Company.




          (b) Recognizing the fact that Executive will be given or have access to the Confidential
Information described in this Section 13 above, and that Executive owes a duty of full loyalty to
the Company and its name, reputation and operational interests, Executive agrees that during the
period of Executive’s employment with the Company, Executive will not engage in or have an interest
in, either directly or indirectly, in any manner, whether as a shareholder, partner, owner,
investor, officer, director, advisor, employee, consultant, or in any other capacity, any
Competitive Business other than an ownership position of less than 5 percent in any company whose
shares are publicly traded.




10









 








          In addition, Executive agrees that in the event that Executive’s employment with the Company
is terminated for any reason by either party, for a period of one (1) year from the date of
termination of employment, Executive will not, either directly or indirectly, whether as a
shareholder, partner, owner, investor, officer, director, advisor, employee or consultant with
responsibilities which are the same or similar as those which Executive had with the Company,
associate with, participate in or have an interest in any Competitive Business (other than an
ownership position by Executive of less than 5% in any company whose shares are publicly traded)
which is located or which operates within 50 miles of:





     (i) any hospital, hospital cardiology or cardiovascular surgery program
or fixed site cardiac catheterization lab in each case which the Company
owns, whether all or in part, or manages or the Company’s corporate
headquarters, or




     (ii) any location with respect to which the Company was actively
developing or negotiating as of the Separation Date to own or manage a
hospital, cardiac catheterization lab or a hospital’s cardiology or
cardiovascular surgery program (for purposes of this section, the term
“actively developing or negotiating” means either definitive documents, a
letter of intent, memorandum of understanding or other comparable document
had been executed or the material terms thereof were being actively
negotiated).



          For purposes of this Section 13, the term “Competitive Business” means any entity that
owns or manages hospitals, cardiac catheterization labs or any portion thereof and that derives,
directly or indirectly, more than 10% of its gross annual revenue from providing cardiology or
cardiovascular-related healthcare services.




          (c) Executive further agrees that in the event Executive’s employment with the Company is
terminated for any reason by either party, for a period of one year from the date of termination of
employment, Executive shall not, on his own behalf or on behalf of any person, firm or company,
directly or indirectly, solicit or offer employment to any person who has been employed by the
Company or its subsidiaries at any time during the 12 months immediately preceding such
solicitation.




          (d) Executive further agrees that in the event Executive’s employment with the Company is
terminated for any reason by either party, he will not communicate orally, in writing or
electronically (through, for example, the internet), including but not limited to, at healthcare,
financial or other conferences, seminars or meetings or at any other place or time,



11









 






generally,
specifically or by implication to any person or entity any opinions or comments regarding the
prospects, competence or skills of the Company or any facts, opinions or comments that could
reasonably be expected to reflect adversely upon the other or disparage, degrade, malign or harm
the reputation of the Company.




          (e) Executive and the Company agree that the covenants in this Section 13 are reasonable
covenants under the circumstances, and further agree that if in the opinion of any court of
competent jurisdiction such restraint is not reasonable in any respect, such court shall have the
right, power and authority to excise or modify such provision or provisions of the covenants as to
the court shall appear not reasonable and to enforce the remainder of the covenants as so amended.
Executive agrees that any breach of the covenants contained in this Section 13 would irreparably
injure the Company. Accordingly, Executive agrees that the Company may, in addition to pursuing
any other remedies it may have in law or in equity, cease making any payments otherwise
required by this Agreement and obtain an injunction against Executive from any court having
jurisdiction over the matter restraining any further violation of this Agreement by Executive.




     14. Compliance with Code Section 409A. Notwithstanding anything in this Agreement to
the contrary, if (a) Executive is a specified employee as of the date of his separation from
service and (b) any amount or benefit that the Company determines would constitute non-exempt
“deferred compensation” for purposes of Section 409A of the Internal Revenue Code of 1986 (the
“Code”) would otherwise be payable or distributable under this Agreement by reason of
Executive’s separation from service, then to the extent necessary to comply with Code Section 409A:
(i) if the payment or distribution is payable in a lump sum, Executive’s right to receive payment
or distribution of such non-exempt deferred compensation will be delayed until the earlier of
Executive’s death or the first day of the seventh month following Executive’s separation from
service, and (ii) if the payment, distribution or benefit is payable or provided over time, the
amount of such non-exempt deferred compensation or benefit that would otherwise be payable or
provided during the six (6) month period immediately following Executive’s separation from service
will be accumulated, and Executive’s right to receive payment or distribution of such accumulated
amount or benefit will be delayed until the earlier of Executive’s death or the first day of the
seventh month following Executive’s separation from service and paid or provided on the earlier of
such dates, without interest, and



12









 







the normal payment or distribution schedule for any remaining
payments, distributions or benefits will commence.



     For purposes of this Agreement, the term “separation from service” shall be defined as
provided in Code Section 409A and applicable regulations, and Executive shall be a “specified
employee” during the twelve (12) month period beginning April 1 each year if Executive met the
requirements of Section 416(i)(1)(A)(i), (ii) or (iii) of the Code (applied in accordance with the
regulations thereunder and disregarding Section 416(i)(5) of the Code) at any time during the
twelve (12) month period ending on the December 31 immediately preceding his separation from
service.



          Notwithstanding anything herein, the parties desire that this agreement is meant and
constructed to comply with Section 409A in its entirety.




     15. Beneficiaries; References. Executive shall be entitled to select (and change, to
the extent permitted under any applicable law) a beneficiary or beneficiaries to receive any
compensation or benefit payable hereunder following Executive’s death, and may change such
election, in either case by giving the Company written notice thereof. In the event of Executive’s
death or a judicial determination of his incompetence, reference in this Agreement to Executive
shall be deemed, where appropriate, to refer to his beneficiary, estate or other legal
representative. Any reference to the masculine gender in this Agreement shall include, where
appropriate, the feminine.



     16. Survivorship. The respective rights and obligations of the parties hereunder
shall survive any termination of this Agreement to the extent necessary to the intended
preservation of such rights and obligations, including the provisions of Section 13 herein. The
provisions of this Section 16 are in addition to the survivorship provisions of any other section
of this Agreement.



     17. Governing Law. This Agreement shall be construed, interpreted and governed in
accordance with the laws of the State of North Carolina without reference to rules relating to
conflicts of law.



     18. Withholding. The Company shall be entitled to withhold from payment any amount of
withholding required by law.



13









 





     19. Counterparts. This Agreement may be executed in two or more counterparts, each of
which will be deemed an original.



	 	 	 	 	 
	 	 	MEDCATH CORPORATION
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Title:
	 	President and Chief Executive Officer
	 
	 	 	 	 
	 	 	 
	 	 	Jeffrey Hinton







14